United Kingdom & Palantir

United Kingdom: The United Kingdom government, through its United Kingdom — National Health Service, is reviewing a significant contract with Palantir, impacting Palantir's international business outlook.

Palantir: Palantir is the central entity of this event, with its stock performance, financial results, and valuation being the primary focus of the articles. The company has experienced significant revenue growth, particularly in its U.S. commercial segment, driven by its Artificial Intelligence Platform (AIP).

Palantir: Palantir was accused by Iran's Revolutionary Guards of complicity in previous killings of Iranian leaders and threatened with destruction of its relevant units.